Table 3 The change of medical quality among treatment and control groups (China, 2016–2021)
Expense categories(yuan) | Treatment group | Control group | DIFF | SDIFF | P-value | ||
|---|---|---|---|---|---|---|---|
pre-implementation | post-implementation | pre-implementation | post-implementation | ||||
panel A: type 2 diabetes | |||||||
Cure rate (%) | 87.10 | 90.77 | 91.81 | 96.53 | 1.060 | 4.905 | 0.834 |
Average length of stay (days) | 7.71 | 7.60 | 9.22 | 6.66 | -2.438 | 0.700 | 0.001*** |
panel B: planned cesarean section | |||||||
Cure rate (%) | 99.37 | 94.80 | 99.54 | 95.49 | 2.127 | 3.765 | 0.588 |
Infection rate (%) | 1.13 | 0.87 | 1.39 | 0.00 | -0.012 | 0.003 | 0.006*** |
Average length of stay (days) | 5.67 | 5.43 | 5.73 | 5.25 | -0.242 | 0.263 | 0.357 |
panel C: Lacunar infarction | |||||||
Cure rate (%) | 86.67 | 86.44 | 89.91 | 97.65 | 8.990 | 5.393 | 0.049** |
Average length of stay (days) | 8.87 | 8.46 | 10.96 | 6.11 | -4.268 | 0.894 | 0.000*** |